XML 54 R10.htm IDEA: XBRL DOCUMENT v2.4.0.8
Financial Instruments
9 Months Ended
Sep. 30, 2014
Investments Debt And Equity Securities [Abstract]  
Financial Instruments

 

 

4. Financial Instruments

Cash equivalents and investments, all of which are classified as available-for-sale securities, consisted of the following (in thousands):

 

 

September 30, 2014

 

 

December 31, 2013

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Estimated

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Estimated

 

 

 

 

 

 

Unrealized

 

 

Unrealized

 

 

Fair

 

 

 

 

 

 

Unrealized

 

 

Unrealized

 

 

Fair

 

 

Cost

 

 

Gain

 

 

(Loss)

 

 

Value

 

 

Cost

 

 

Gain

 

 

(Loss)

 

 

Value

 

Money market funds

$

13,588

 

 

$

 

 

$

 

 

$

13,588

 

 

$

57,296

 

 

$

 

 

$

 

 

$

57,296

 

Corporate notes and commercial paper

 

164,048

 

 

 

30

 

 

 

(72

)

 

 

164,006

 

 

 

182,426

 

 

 

62

 

 

 

(16

)

 

 

182,472

 

U.S. government agency securities

 

60,978

 

 

 

20

 

 

 

(2

)

 

 

60,996

 

 

 

75,278

 

 

 

23

 

 

 

(12

)

 

 

75,289

 

 

$

238,614

 

 

$

50

 

 

$

(74

)

 

$

238,590

 

 

$

315,000

 

 

$

85

 

 

$

(28

)

 

$

315,057

 

Classified as:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Cash equivalents

 

 

 

 

 

 

 

 

 

 

 

 

$

29,727

 

 

 

 

 

 

 

 

 

 

 

 

 

 

$

113,794

 

Short-term investments

 

 

 

 

 

 

 

 

 

 

 

 

 

172,060

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

150,892

 

Long-term investments

 

 

 

 

 

 

 

 

 

 

 

 

 

36,803

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

50,371

 

Total cash equivalents and investments

 

 

 

 

 

 

 

 

 

 

 

 

$

238,590

 

 

 

 

 

 

 

 

 

 

 

 

 

 

$

315,057

 

 

At September 30, 2014 and December 31, 2013, the remaining contractual maturities of available-for-sale securities were less than two years. There have been no significant realized gains or losses on available-for-sale securities for the periods presented.